Iovance Biotherapeutics (IOVA) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.8
-0.68
-0.57
-0.45

Details

Expected EPS
-0.45
Actual EPS
-0.46
Surprise EPS
-0.01
Surprise Percent
+2.22%

Description

Iovance Biotherapeutics (IOVA) has reported earnings of -0.46 per share for Q3 2023.

0 Comments

Share your thoughts